Form 4: Hyperfine Director John Dahldorf Receives Stock Options

Director John T. Dahldorf was granted 157,700 stock options in Hyperfine, Inc. as part of his compensation.

Summary

• Director John T. Dahldorf received a grant of 157,700 stock options on May 22, 2026.
• The options have an exercise price of $1.49 per share.
• The options are set to expire on May 22, 2036.
• Vesting is scheduled to occur on the date of the Issuer's next regular annual stockholders meeting, contingent upon continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no immediate impact on company operations or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential future dilution of existing shareholders upon the exercise of these options.

Risks

• Vesting is subject to the director's continued service, creating a dependency on personnel retention.

Future Outlook

The options vest at the next annual stockholders meeting, indicating a standard annual equity grant cycle for board members.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of stock options to non-employee directors is consistent with standard compensation practices for mid-cap and small-cap technology and medical device companies.

Corporate Governance

Stakeholder Impact

• Minor potential dilution for shareholders upon future exercise of options.

Next Steps

• Vesting of options at the next annual stockholders meeting.

Key Dates

Keywords

Hyperfine, HYPR, Form 4, Insider Trading, Stock Options, Director Compensation